Pirfenidone Tablet, Film Coated
Product Images NDC 60219-1640

8 FDA label images from Amneal Pharmaceuticals Ny Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 60219-1640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B (Pirfenidone Tablets 1)

B (Pirfenidone Tablets 1)
Chemical structure of pirfenidone, showing a pyridone ring substituted with a methyl group and a phenyl group attached to the nitrogen atom.*
FDA Label Image

W (Pirfenidone Tablets 2)

W (Pirfenidone Tablets 2)
A line graph comparing the percentage of patients with changes in %FVC from baseline to week 52 for Pirfenidone and Placebo groups. The X-axis shows absolute change in %FVC ranging from -30 to 10, and the Y-axis shows the percentage of patients from 0% to 100%. The chart highlights 32%, 17%, 90%, and 77% patient response values for groups under worsening or no decline conditions.*
FDA Label Image

G (Pirfenidone Tablets 3)

G (Pirfenidone Tablets 3)
A line graph depicting mean change in forced vital capacity (FVC) over 52 weeks comparing Pirfenidone (solid line) and placebo (dashed line) groups. The graph shows a decrease in FVC for both groups across weeks, with the placebo group experiencing a larger decline than the Pirfenidone group.*
FDA Label Image

N (Pirfenidone Tablets 4)

N (Pirfenidone Tablets 4)
A Kaplan-Meier survival curve comparing the percentage of patients alive over time (in weeks) for Pirfenidone versus placebo groups. The graph plots patient survival from 0 to 120 weeks, including numbers of patients at risk at various time points. Hazard ratio with confidence interval is also shown, illustrating survival comparison between treatments.*
FDA Label Image

Gt (Pirfenidone Tablets 5)

Gt (Pirfenidone Tablets 5)
Label of Pirfenidone Tablets 267 mg film-coated tablets by Amneal Pharmaceuticals NY LLC. The label states each tablet contains 267 mg of pirfenidone and notes storage conditions between 20° to 25°C with permitted excursions. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. Oral Solid Dosage Unit in Ahmedabad, India. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Contains 90 tablets, prescription only.*
FDA Label Image

10 (Pirfenidone Tablets 6)

10 (Pirfenidone Tablets 6)
Carton packaging for Pirfenidone Tablets 267 mg oral use by Amneal Pharmaceuticals NY LLC. The box contains 270 film-coated tablets divided into 3 bottles of 90 tablets each. The label includes storage instructions and dosage advisory. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, India.*
FDA Label Image

10 (Pirfenidone Tablets 7)

10 (Pirfenidone Tablets 7)
Label for Pirfenidone Tablets 801 mg film-coated tablets, prescription drug by Amneal Pharmaceuticals NY LLC. The label includes the NDC 60219-1641-9, dosage strength, and image of a brown oval tablet engraved AC70. Manufacturer is Amneal Pharmaceuticals Pvt. Ltd., India; distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Storage instructions and a barcode are also visible.*
FDA Label Image

10 (Pirfenidone Tablets 8)

10 (Pirfenidone Tablets 8)
Carton label for Pirfenidone Tablets 801 mg, film-coated oral tablets. The label shows the NDC number 60219-1641-9 and the dosage strength prominently. It is manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. The carton holds 90 tablets and includes storage instructions and warnings to keep the bottle tightly closed and out of children's reach. The Amneal logo appears at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.